Moreover, first functional evaluation proofed that blockade of TIGIT and/or PVRIG prevented NK cell exhaustion and promotes NK cell–dependent tumor immunity in solid and hematological tumor models [24, 63]. The gene discussed is TIGIT; the disease is neoplasm.